{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:26:55Z","timestamp":1775978815192,"version":"3.50.1"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005054","name":"Nantong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mam.2025.101427","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T14:39:09Z","timestamp":1763995149000},"page":"101427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Viral pathogens in bone- and bone-marrow derived malignancies: Friends or foes?"],"prefix":"10.1016","volume":"106","author":[{"given":"Pei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianlei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anquan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib1","article-title":"Osteosarcoma: cells\u2010of\u2010origin, cancer stem cells, and targeted therapies","volume":"2016","author":"Abarrategi","year":"2016","journal-title":"Stem Cell. Int."},{"issue":"2","key":"10.1016\/j.mam.2025.101427_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2023.103920","article-title":"An overview of multiple myeloma: a monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities","volume":"31","author":"Abduh","year":"2024","journal-title":"Saudi J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.mam.2025.101427_bib3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/cells10061541","article-title":"Oncolytic herpes simplex virus-based therapies for cancer","volume":"10","author":"Aldrak","year":"2021","journal-title":"Cells"},{"issue":"20","key":"10.1016\/j.mam.2025.101427_bib4","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.3390\/cancers14205125","article-title":"TRAIL in the treatment of cancer: from soluble cytokine to nanosystems","volume":"14","author":"Alizadeh Zeinabad","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2025.101427_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.omto.2020.09.010","article-title":"Oncolytic reovirus-mediated recruitment of early innate immune responses reverses immunotherapy resistance in prostate tumors","volume":"20","author":"Annels","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib6","first-page":"62","article-title":"Acute myeloid leukemia","volume":"2001","author":"Appelbaum","year":"2001","journal-title":"ASH Educat. Program Book"},{"issue":"6","key":"10.1016\/j.mam.2025.101427_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/v17060802","article-title":"Progress in pseudotyping lentiviral vectors towards cell-specific gene delivery in vivo","volume":"17","author":"Arduini","year":"2025","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.mam.2025.101427_bib8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/v8100294","article-title":"Measles to the rescue: a review of oncolytic measles virus","volume":"8","author":"Aref","year":"2016","journal-title":"Viruses"},{"issue":"1\u20132","key":"10.1016\/j.mam.2025.101427_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.beha.2017.02.001","article-title":"Hepatitis C virus\u2013associated marginal zone lymphoma","volume":"30","author":"Armand","year":"2017","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"5","key":"10.1016\/j.mam.2025.101427_bib10","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/1759-7714.13043","article-title":"Updates to the antitumor mechanism of oncolytic virus","volume":"10","author":"Bai","year":"2019","journal-title":"Thorac. Cancer"},{"issue":"4","key":"10.1016\/j.mam.2025.101427_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clml.2015.12.005","article-title":"Myxoma virus induces ligand independent extrinsic apoptosis in human myeloma cells","volume":"16","author":"Bartee","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"2","key":"10.1016\/j.mam.2025.101427_bib12","first-page":"358","article-title":"Vertebral metastasis of hepatocellular carcinoma secondary to viral hepatitis B: case report of 2 patients","volume":"77","author":"Bayala","year":"2024","journal-title":"Index. Pubmed\/Medline Scopus Embase Ebsco Index Copernicus Polish Ministry Sci. Higher Educat. Polish Med. Bibliograph."},{"issue":"15","key":"10.1016\/j.mam.2025.101427_bib13","doi-asserted-by":"crossref","first-page":"10782","DOI":"10.1021\/acs.jmedchem.3c00990","article-title":"Disrupting kaposi's sarcoma-associated herpesvirus (KSHV) latent replication with a small molecule inhibitor","volume":"66","author":"Berwanger","year":"2023","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.mam.2025.101427_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/hum.2012.203","article-title":"Mechanisms of retroviral integration and mutagenesis","volume":"24","author":"Cavazza","year":"2013","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.mam.2025.101427_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.onc.1209055","article-title":"Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia","volume":"25","author":"Cesaire","year":"2006","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.mam.2025.101427_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10637-015-0216-8","article-title":"The oncolytic virus, pelareorep, as a novel anticancer agent: a review","volume":"33","author":"Chakrabarty","year":"2015","journal-title":"Invest. N. Drugs"},{"issue":"3","key":"10.1016\/j.mam.2025.101427_bib17","first-page":"1344","article-title":"Clonal expansion of immunoglobulin M+ CD27+ B cells in HCV-associated mixed cryoglobulinemia","volume":"111","author":"Charles","year":"2008","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"4","key":"10.1016\/j.mam.2025.101427_bib18","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3390\/cancers6042155","article-title":"Viral carcinogenesis: factors inducing DNA damage and virus integration","volume":"6","author":"Chen","year":"2014","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.mam.2025.101427_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/gcc.22336","article-title":"Ewing sarcoma with ERG gene rearrangements: a molecular study focusing on the prevalence of FUS\u2010ERG and common pitfalls in detecting EWSR1\u2010ERG fusions by FISH","volume":"55","author":"Chen","year":"2016","journal-title":"Gene Chromosome Cancer"},{"issue":"10","key":"10.1016\/j.mam.2025.101427_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016653118","article-title":"Kaposi's sarcoma herpesvirus is associated with osteosarcoma in Xinjiang populations","volume":"118","author":"Chen","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib21","article-title":"A novel defined RAS\u2010Related gene signature for predicting the prognosis and characterization of biological function in Osteosarcoma","volume":"2022","author":"Chen","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.mam.2025.101427_bib22","article-title":"Current status and research progress of oncolytic virus","volume":"2","author":"Chen","year":"2024","journal-title":"Pharmaceutical Sc. Adv."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/annonc\/mdx635","article-title":"From hepatitis C virus infection to B-cell lymphoma","volume":"29","author":"Couronn\u00e9","year":"2018","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.mam.2025.101427_bib24","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.3390\/cancers12113327","article-title":"Hitting the target but missing the point: recent progress towards adenovirus-based precision virotherapies","volume":"12","author":"Cunliffe","year":"2020","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.mam.2025.101427_bib25","article-title":"Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine","volume":"4","author":"Dan","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"12","key":"10.1016\/j.mam.2025.101427_bib26","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1128\/JVI.75.12.5443-5447.2001","article-title":"Does the antitumor adenovirus ONYX-015\/dl1520 selectively target cells defective in the p53 pathway?","volume":"75","author":"Dix","year":"2001","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.mam.2025.101427_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/cgt.2014.54","article-title":"Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcoma","volume":"21","author":"Domingo-Musibay","year":"2014","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s44337-024-00082-y","article-title":"Unlocking the potential: a specific focus on vesicular stomatitis virus as a promising oncolytic and immunomodulatory agent in cancer therapy","volume":"1","author":"Elnosary","year":"2024","journal-title":"Discov. Med."},{"issue":"20","key":"10.1016\/j.mam.2025.101427_bib29","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.3390\/cancers13205066","article-title":"The effect of a histone deacetylase inhibitor (AR-42) and zoledronic acid on adult T-cell Leukemia\/Lymphoma osteolytic bone tumors","volume":"13","author":"Elshafae","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.mam.2025.101427_bib30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/cancers13030544","article-title":"Measles virus as an oncolytic immunotherapy","volume":"13","author":"Engeland","year":"2021","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.mam.2025.101427_bib31","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.7150\/jca.25460","article-title":"The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma","volume":"9","author":"Fan","year":"2018","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.mam.2025.101427_bib32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/cancers13061383","article-title":"Talimogene laherparepvec (T-VEC): an intralesional cancer immunotherapy for advanced melanoma","volume":"13","author":"Ferrucci","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2025.101427_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbo.2016.12.001","article-title":"Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: a new hope","volume":"9","author":"Garcia-Moure","year":"2017","journal-title":"J. Bone Oncol."},{"issue":"10","key":"10.1016\/j.mam.2025.101427_bib34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/v9100301","article-title":"Preclinical testing of an oncolytic parvovirus: standard protoparvovirus H-1PV efficiently induces osteosarcoma cell lysis in vitro","volume":"9","author":"Geiss","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.mam.2025.101427_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105834","article-title":"Viral and non-viral vectors in gene therapy: current state and clinical perspectives","volume":"118","author":"Geng","year":"2025","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12964-023-01232-y","article-title":"Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery","volume":"21","author":"Ghaleh","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.mam.2025.101427_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fonc.2014.00167","article-title":"Activated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells","volume":"4","author":"Gong","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mam.2025.101427_bib38","first-page":"13","article-title":"Bone marrow niches and tumour cells: lights and shadows of a mutual relationship","author":"Granata","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2025.101427_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.01.002","article-title":"Preexisting immunity: barrier or bridge to effective oncolytic virus therapy?","volume":"70","author":"Groeneveldt","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.mam.2025.101427_bib40","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/biology2020587","article-title":"Antitumor virotherapy by attenuated measles virus (MV)","volume":"2","author":"Guillerme","year":"2013","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40425-018-0495-7","article-title":"Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics","volume":"7","author":"Guo","year":"2019","journal-title":"J. Immunotherapy Cancer"},{"key":"10.1016\/j.mam.2025.101427_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fonc.2017.00096","article-title":"Genetically engineered vaccinia viruses as agents for cancer treatment, imaging, and transgene delivery","volume":"7","author":"Haddad","year":"2017","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.mam.2025.101427_bib43","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/cancers12061504","article-title":"Oncolytic adenoviruses: strategies for improved targeting and specificity","volume":"12","author":"Hajeri","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.6004\/jnccn.2017.7024","article-title":"Frequency, morbidity, and mortality of bone metastases in advanced hepatocellular carcinoma","volume":"16","author":"Harding","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"8","key":"10.1016\/j.mam.2025.101427_bib45","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/cncr.25741","article-title":"Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts","volume":"117","author":"Hingorani","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.mam.2025.101427_bib46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4236\/ojra.2021.114015","article-title":"Bone metastases indicative of post viral hepatitis C hepatocarcinoma: about two observations","volume":"11","author":"Houzou","year":"2021","journal-title":"Open J. Rheumatol. Autoimmune Dis."},{"issue":"2","key":"10.1016\/j.mam.2025.101427_bib47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/1568009623666230512153741","article-title":"The role of LMP1 in Epstein-Barr virus-associated gastric cancer","volume":"24","author":"Huang","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.mam.2025.101427_bib48","series-title":"Preclinical Evaluation of an Engineered Oncolytic Herpes simplex Virus for Pediatric Osteosarcoma","author":"Hutchins","year":"2021"},{"issue":"3","key":"10.1016\/j.mam.2025.101427_bib49","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.18632\/oncotarget.13904","article-title":"Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis","volume":"8","author":"Ivanov","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.mam.2025.101427_bib50","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/biomedicines13040950","article-title":"Immunogenic cell death and metabolic reprogramming in cancer: mechanisms, synergies, and innovative therapeutic strategies","volume":"13","author":"Jiang","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12935-025-03741-x","article-title":"Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword","volume":"25","author":"Kamrani","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.mam.2025.101427_bib52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10555-006-9036-9","article-title":"Bone marrow cells in the \u2018pre-metastatic niche\u2019: within bone and beyond","volume":"25","author":"Kaplan","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.mam.2025.101427_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2024.110619","article-title":"Burkitt's lymphoma with multi-organ involvement","volume":"125","author":"Karimi","year":"2024","journal-title":"Int. J. Surg. Case Rep."},{"issue":"2","key":"10.1016\/j.mam.2025.101427_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.70023","article-title":"Nuclear factor of activated T cells signalling and viral pathogens: a dynamic cross\u2010talk","volume":"35","author":"Khanizadeh","year":"2025","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.mam.2025.101427_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.omto.2023.100729","article-title":"Breaking the barriers in cancer care: the next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment","volume":"31","author":"Khushalani","year":"2023","journal-title":"Mol. Ther. Oncolytics"},{"issue":"7","key":"10.1016\/j.mam.2025.101427_bib56","first-page":"811","article-title":"Myeloid malignancies and the microenvironment","volume":"129","author":"Korn","year":"2017","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"6","key":"10.1016\/j.mam.2025.101427_bib57","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/v10060302","article-title":"Preclinical testing of an oncolytic parvovirus in Ewing sarcoma: protoparvovirus H-1 induces apoptosis and lytic infection in vitro but fails to improve survival in vivo","volume":"10","author":"Lacroix","year":"2018","journal-title":"Viruses"},{"issue":"14","key":"10.1016\/j.mam.2025.101427_bib58","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.3748\/wjg.v12.i14.2297","article-title":"Development of multiple myeloma in a patient with chronic hepatitis C: a case report and review of the literature","volume":"12","author":"Lakatos","year":"2006","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"4","key":"10.1016\/j.mam.2025.101427_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040893","article-title":"New insights into the multifaceted role of Myeloid-Derived suppressor cells (MDSCs) in high-grade gliomas: from metabolic reprograming, immunosuppression, and therapeutic resistance to Current strategies for targeting MDSCs","volume":"10","author":"Lakshmanachetty","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mam.2025.101427_bib60","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/OTT.S518407","article-title":"Measles virus-based genetic modifications: progress in hematological malignancy treatment","author":"Lan","year":"2025","journal-title":"OncoTargets Ther."},{"issue":"2","key":"10.1016\/j.mam.2025.101427_bib61","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ajpath.2020.10.014","article-title":"In vivo tumorigenesis, osteolytic sarcomas, and tumorigenic cell lines from transgenic mice expressing the human T-lymphotropic virus type 1 (HTLV-1) tax viral oncogene","volume":"191","author":"Lanigan","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.mam.2025.101427_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/his.14085","article-title":"Diagnosis of classic Hodgkin lymphoma on bone marrow biopsy","volume":"76","author":"Laurent","year":"2020","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.mam.2025.101427_bib63","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/BF02256110","article-title":"Epstein-Barr virus latent membrane protein 1: structure and functions","volume":"10","author":"Li","year":"2003","journal-title":"J. Biomed. Sci."},{"issue":"3","key":"10.1016\/j.mam.2025.101427_bib64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/imj.12981","article-title":"Association between hepatitis B virus infection and risk of multiple myeloma: a systematic review and meta\u2010analysis","volume":"46","author":"Li","year":"2016","journal-title":"Intern. Med. J."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib65","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/0008-5472.CAN-17-1961","article-title":"Evidence for Kaposi sarcoma originating from mesenchymal stem cell through KSHV-induced mesenchymal-to-endothelial transition","volume":"78","author":"Li","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.mam.2025.101427_bib66","article-title":"Roles of the RANKL\u2013RANK axis in immunity\u2014Implications for pathogenesis and treatment of bone metastasis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2025.101427_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101371","article-title":"Cardiovascular impact of emerging and Re-emerging viruses: pathophysiological mechanisms, diagnosis, and management with a pediatric focus","volume":"104","author":"Li","year":"2025","journal-title":"Mol. Aspect. Med."},{"issue":"6","key":"10.1016\/j.mam.2025.101427_bib68","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00223-012-9653-y","article-title":"Association between chronic hepatitis C virus infection and bone mineral density","volume":"91","author":"Lin","year":"2012","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib69","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"28","key":"10.1016\/j.mam.2025.101427_bib70","doi-asserted-by":"crossref","first-page":"24978","DOI":"10.18632\/oncotarget.4617","article-title":"Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.mam.2025.101427_bib71","article-title":"An uncommon progression of a common AIDS-Defining diagnosis: metastatic kaposi sarcoma to lung and bone","volume":"3","author":"Lo","year":"2024","journal-title":"Ann. Intern. Med.: Clin. Cases"},{"issue":"16","key":"10.1016\/j.mam.2025.101427_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164178","article-title":"Oncolytic viruses and immune checkpoint inhibitors: the \"Hot\" new power couple","volume":"15","author":"Lovatt","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib73","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41419-020-2236-3","article-title":"Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer","volume":"11","author":"Ma","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.mam.2025.101427_bib74","first-page":"218","article-title":"Seronegative occult hepatitis C infection among hemodialysis patients: a prevalence study. Therapeutic Apheresis and Dialysis","volume":"25","author":"Mahmoudvand","year":"2021"},{"issue":"9","key":"10.1016\/j.mam.2025.101427_bib75","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.31557\/APJCP.2021.22.9.2939","article-title":"Frequency of hepatitis B virus infection among patients before chemotherapy treatment","volume":"22","author":"Mahmoudvand","year":"2021","journal-title":"Asian Pac. J. Cancer Prev. APJCP: Asian Pac. J. Cancer Prev. APJCP"},{"issue":"11","key":"10.1016\/j.mam.2025.101427_bib76","doi-asserted-by":"crossref","DOI":"10.1177\/1010428320974247","article-title":"Co-expression of Epstein\u2013Barr virus\u2013encoded RNA1 and viral latent membrane protein 1 in osteosarcoma: a novel insight of predictive markers","volume":"42","author":"Mardanpour","year":"2020","journal-title":"Tumor Biol."},{"issue":"9","key":"10.1016\/j.mam.2025.101427_bib77","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1158\/1078-0432.CCR-15-1899","article-title":"The oncolytic adenovirus VCN-01 as therapeutic approach against pediatric osteosarcoma","volume":"22","author":"Mart\u00ednez-V\u00e9lez","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"24","key":"10.1016\/j.mam.2025.101427_bib78","first-page":"8751","article-title":"Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes","volume":"61","author":"McCart","year":"2001","journal-title":"Cancer Res."},{"issue":"56","key":"10.1016\/j.mam.2025.101427_bib79","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1038\/sj.onc.1204096","article-title":"ONYX-015 selectivity and the p14ARF pathway","volume":"19","author":"McCormick","year":"2000","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.mam.2025.101427_bib80","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbadis.2007.12.005","article-title":"Viruses associated with human cancer","volume":"1782","author":"McLaughlin-Drubin","year":"2008","journal-title":"Biochimica et Biophysica Acta (BBA)-Mole. Basis Disease"},{"issue":"5","key":"10.1016\/j.mam.2025.101427_bib81","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"M\u00e9ndez-Ferrer","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.mam.2025.101427_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020167","article-title":"IL-12 family cytokines in cancer and immunotherapy","volume":"13","author":"Mirlekar","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.mam.2025.101427_bib83","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1002\/jcp.26194","article-title":"Role of viruses in gastrointestinal cancer","volume":"233","author":"Mirzaei","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2085","article-title":"Histone deacetylases in virus\u2010associated cancers","volume":"30","author":"Mirzaei","year":"2020","journal-title":"Rev. Med. Virol."},{"issue":"10","key":"10.1016\/j.mam.2025.101427_bib85","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1080\/21645515.2020.1723363","article-title":"Recent advances of oncolytic virus in cancer therapy","volume":"16","author":"Mondal","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"issue":"4","key":"10.1016\/j.mam.2025.101427_bib86","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0168-9525(98)01408-5","article-title":"Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV","volume":"14","author":"Moore","year":"1998","journal-title":"Trends Genet."},{"issue":"5293","key":"10.1016\/j.mam.2025.101427_bib87","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.274.5293.1739","article-title":"Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV","volume":"274","author":"Moore","year":"1996","journal-title":"Science"},{"issue":"32","key":"10.1016\/j.mam.2025.101427_bib88","doi-asserted-by":"crossref","first-page":"16046","DOI":"10.1073\/pnas.1901314116","article-title":"Epstein\u2013Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection","volume":"116","author":"Mrozek-Gorska","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.mam.2025.101427_bib89","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.3390\/cancers12113219","article-title":"Past, present and future of oncolytic reovirus","volume":"12","author":"M\u00fcller","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.mam.2025.101427_bib90","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","article-title":"Latency and lytic replication in Epstein\u2013Barr virus-associated oncogenesis","volume":"17","author":"M\u00fcnz","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.mam.2025.101427_bib91","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2014.02.003","article-title":"Cells of origin in osteosarcoma: mesenchymal stem cells or osteoblast committed cells?","volume":"62","author":"Mutsaers","year":"2014","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.mam.2025.101427_bib92","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ccr.2004.11.012","article-title":"Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity","volume":"6","author":"O'Shea","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mam.2025.101427_bib93","series-title":"Osteoporosis Rehabilitation: a Practical Approach","first-page":"349","article-title":"Bone disorders in cancer","author":"Oleson","year":"2017"},{"key":"10.1016\/j.mam.2025.101427_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1618751","article-title":"Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer's defenses","volume":"16","author":"Omolekan","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.mam.2025.101427_bib95","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.exphem.2006.03.002","article-title":"Oncolytic measles virus targets high CD46 expression on multiple myeloma cells","volume":"34","author":"Ong","year":"2006","journal-title":"Exp. Hematol."},{"issue":"9","key":"10.1016\/j.mam.2025.101427_bib96","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/14712598.2020.1757066","article-title":"Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity","volume":"20","author":"Pelin","year":"2020","journal-title":"Expet Opin. Biol. Ther."},{"issue":"11","key":"10.1016\/j.mam.2025.101427_bib97","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cmi.2015.07.009","article-title":"Immunodeficiency-associated viral oncogenesis","volume":"21","author":"Pierangeli","year":"2015","journal-title":"Clin. Microbiol. Infection"},{"issue":"10","key":"10.1016\/j.mam.2025.101427_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12516","article-title":"HTLV\u20101 infected T cells cause bone loss via small extracellular vesicles","volume":"13","author":"Pokhrel","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.mam.2025.101427_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1513834","article-title":"Metal ions and nanomaterials for targeted bone cancer immunotherapy","volume":"16","author":"Qin","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.167.1.21","article-title":"Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients","volume":"167","author":"Racanelli","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.mam.2025.101427_bib101","series-title":"The Epstein-Barr Virus and Osteosarcoma in Iranian Children","author":"Rahbar","year":"2020"},{"issue":"2\u20133","key":"10.1016\/j.mam.2025.101427_bib102","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cytogfr.2010.02.010","article-title":"Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus","volume":"21","author":"Rahman","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.mam.2025.101427_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1483806","article-title":"Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients","volume":"15","author":"Raimondi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2025.101427_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106271","article-title":"Epigenetics regulation during virus-host interaction and their effects on the virus and host cell","volume":"182","author":"Rehman","year":"2023","journal-title":"Microb. Pathog."},{"issue":"5320","key":"10.1016\/j.mam.2025.101427_bib105","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1126\/science.276.5320.1851","article-title":"KSHV infection of multiple myeloma bone marrow stroma","volume":"276","author":"Rettig","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mam.2025.101427_bib106","doi-asserted-by":"crossref","first-page":"63","DOI":"10.31083\/j.fbl2702063","article-title":"Oncolytic viruses in melanoma","volume":"27","author":"Robinson","year":"2022","journal-title":"Front. Biosci."},{"issue":"6","key":"10.1016\/j.mam.2025.101427_bib107","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1158\/1078-0432.CCR-14-2213","article-title":"Safety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase expression","volume":"21","author":"Rodr\u00edguez-Garc\u00eda","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.mam.2025.101427_bib108","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/jmp4020011","article-title":"Different subtypes of osteosarcoma: histopathological patterns and clinical behaviour","volume":"4","author":"Rothzerg","year":"2023","journal-title":"J. Mole. Pathol."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib109","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12964-025-02283-z","article-title":"Extracellular vesicles as missiles for enhanced anti-tumor efficacy of oncolytic viruses: from disseminating oncolysis and anti-tumor immunity to targeted delivery","volume":"23","author":"Safarzadeh","year":"2025","journal-title":"Cell Commun. Signal."},{"issue":"11","key":"10.1016\/j.mam.2025.101427_bib110","first-page":"4278","article-title":"Localization of Kaposi's sarcoma\u2013associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma","volume":"90","author":"Said","year":"1997","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"3","key":"10.1016\/j.mam.2025.101427_bib111","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2249.1996.tb08296.x","article-title":"Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non\u2010isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV\u2010infected patients","volume":"103","author":"Sansonno","year":"1996","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.mam.2025.101427_bib112","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/17474086.2021.1972802","article-title":"Advances in viral oncolytics for treatment of multiple myeloma\u2013a focused review","volume":"14","author":"Sarwar","year":"2021","journal-title":"Expet Rev. Hematol."},{"issue":"10","key":"10.1016\/j.mam.2025.101427_bib113","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1158\/1078-0432.CCR-22-1961","article-title":"The oncolytic adenovirus XVir-N-31 joins forces with CDK4\/6 inhibition augmenting innate and adaptive antitumor immunity in Ewing sarcoma","volume":"29","author":"Schober","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mam.2025.101427_bib114","series-title":"Imaging, and Current Therapy","first-page":"305","article-title":"Post-transplant lymphoproliferative disorders. Non-Hodgkin Lymphoma: pathology","author":"Singavi","year":"2015"},{"issue":"15","key":"10.1016\/j.mam.2025.101427_bib115","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.3390\/cancers17152571","article-title":"Modeling the bone marrow microenvironment to better understand the pathogenesis, progression, and treatment of hematological cancers","volume":"17","author":"Skelding","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2025.101427_bib116","series-title":"Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (Atmps)","first-page":"429","article-title":"Oncolytic viruses and viral gene therapy vectors: principles of safety","author":"Spiesschaert","year":"2023"},{"issue":"7","key":"10.1016\/j.mam.2025.101427_bib117","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/leu.2011.66","article-title":"Roles of the Ras\/Raf\/MEK\/ERK pathway in leukemia therapy","volume":"25","author":"Steelman","year":"2011","journal-title":"Leukemia"},{"issue":"1\u20133","key":"10.1016\/j.mam.2025.101427_bib118","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0171-2985(97)80050-2","article-title":"Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J\u03ba","volume":"198","author":"Strobl","year":"1997","journal-title":"Immunobiology"},{"key":"10.1016\/j.mam.2025.101427_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1143258","article-title":"New insights into hepatitis B virus lymphotropism: implications for HBV-related lymphomagenesis","volume":"13","author":"Svicher","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mam.2025.101427_bib120","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1590\/S1807-59322011001200010","article-title":"Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes","volume":"66","author":"Teng","year":"2011","journal-title":"Clinics"},{"issue":"7","key":"10.1016\/j.mam.2025.101427_bib121","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/biology14070797","article-title":"The impact of oncogenic viruses on cancer development: a narrative review","volume":"14","author":"Torres","year":"2025","journal-title":"Biology"},{"issue":"10","key":"10.1016\/j.mam.2025.101427_bib122","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/v10100538","article-title":"Oncogenic signaling induced by HCV infection","volume":"10","author":"Virz\u00ec","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib123","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41392-020-0135-9","article-title":"Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"5","key":"10.1016\/j.mam.2025.101427_bib124","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004167","article-title":"Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment","volume":"10","author":"Wang","year":"2022","journal-title":"J. Immunotherapy Cancer"},{"issue":"21","key":"10.1016\/j.mam.2025.101427_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215291","article-title":"Clinical advances and future directions of oncolytic virotherapy for head and neck cancer","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.mam.2025.101427_bib126","first-page":"1071","article-title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1\u2013infected T cells","volume":"129","author":"Watanabe","year":"2017","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib127","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/v2010078","article-title":"Oncolytic viruses for cancer therapy: overcoming the obstacles","volume":"2","author":"Wong","year":"2010","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.mam.2025.101427_bib128","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1200\/JCO.2005.04.074","article-title":"TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study","volume":"23","author":"Wunder","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.mam.2025.101427_bib129","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190284","article-title":"Epstein\u2013Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma","volume":"39","author":"Xia","year":"2019","journal-title":"Biosci. Rep."},{"issue":"19","key":"10.1016\/j.mam.2025.101427_bib130","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128713","article-title":"HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia","volume":"4","author":"Xiang","year":"2019","journal-title":"JCI Insight"},{"issue":"19","key":"10.1016\/j.mam.2025.101427_bib131","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128713","article-title":"HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia","volume":"4","author":"Xiang","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib132","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40164-025-00655-2","article-title":"Molecular mechanisms of viral oncogenesis in haematological malignancies: perspectives from metabolic reprogramming, epigenetic regulation and immune microenvironment remodeling","volume":"14","author":"Xiao","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib133","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41392-025-02197-9","article-title":"Viral oncogenesis in cancer: from mechanisms to therapeutics","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.mam.2025.101427_bib134","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1038\/bcj.2017.28","article-title":"Prevalence of hepatitis B and hepatitis C viral infections in various subtypes of B-cell Non-Hodgkin lymphoma: confirmation of the association with splenic marginal zone lymphoma","volume":"7","author":"Xiong","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.mam.2025.101427_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1506632","article-title":"GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer","volume":"15","author":"Xuan","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2025.101427_bib136","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3390\/biomedicines13040882","article-title":"Oncolytic Vaccinia virus armed with GM-CSF and IL-7 enhances antitumor immunity in pancreatic cancer","volume":"13","author":"Yan","year":"2025","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.mam.2025.101427_bib137","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/jir.2014.0032","article-title":"Serum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases","volume":"34","author":"Yang","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"issue":"6","key":"10.1016\/j.mam.2025.101427_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061706","article-title":"High-Risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis","volume":"19","author":"Yeo-Teh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.mam.2025.101427_bib139","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00705-014-2094-3","article-title":"Kaposi's sarcoma-associated herpesvirus infection of human bone-marrow-derived mesenchymal stem cells and their angiogenic potential","volume":"159","author":"Yoo","year":"2014","journal-title":"Arch. Virol."},{"issue":"3","key":"10.1016\/j.mam.2025.101427_bib140","first-page":"399","article-title":"HBV integration induces complex interactions between host and viral genomic functions at the insertion site","volume":"9","author":"Zhang","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib141","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12935-021-01972-2","article-title":"Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy","volume":"21","author":"Zhang","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.mam.2025.101427_bib142","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1080\/21645515.2020.1840887","article-title":"Vaccinia virus-based vector against infectious diseases and tumors","volume":"17","author":"Zhang","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"issue":"4","key":"10.1016\/j.mam.2025.101427_bib143","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.70053","article-title":"The role of Emerging\/Re\u2010Emerging RNA viruses in bone\u2010related diseases with a focus on DENV, CHIKV, and SARS\u2010CoV\u20102","volume":"35","author":"Zhang","year":"2025","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.mam.2025.101427_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1649891","article-title":"FLT3L combined with GM-CSF induced dendritic cells drive broad tumor-specific CD8+ T cell responses and remodel the tumor microenvironment to enhance anti-tumor efficacy","volume":"16","author":"Zheng","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12885-019-5718-x","article-title":"Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell Non-Hodgkin lymphoma","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.mam.2025.101427_bib146","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1084\/jem.20171093","article-title":"Zika virus has oncolytic activity against glioblastoma stem cells","volume":"214","author":"Zhu","year":"2017","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.mam.2025.101427_bib147","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12943-022-01664-z","article-title":"Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways","volume":"21","author":"Zhu","year":"2022","journal-title":"Mol. Cancer"}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T21:19:31Z","timestamp":1766092771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299725000913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":147,"alternative-id":["S0098299725000913"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2025.101427","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral pathogens in bone- and bone-marrow derived malignancies: Friends or foes?","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2025.101427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101427"}}